2025/2026 WITH 100% ACCURATE ANSWERS
1. Which can cause serotonin syndrome?
triptans
ondansetron
tricyclics
SSRIs
MAOIs
all of the above
2. Describe the mechanism of action of NDRIs in treating mental health
conditions.
NDRIs work by inhibiting the reuptake of norepinephrine and
dopamine, increasing their levels in the brain.
NDRIs block serotonin receptors to reduce anxiety.
NDRIs enhance the breakdown of neurotransmitters to improve
mood.
NDRIs primarily increase serotonin levels to alleviate depression.
3. What does NDRI stand for in the context of mental health medications?
Norepinephrine-dopamine receptor inhibitors
Norepinephrine-dopamine reuptake inhibitors
Neurotransmitter-dopamine reuptake inhibitors
,Neurotransmitter-dopamine receptor inhibitors
,4. Upon initiating antidepressant therapy, improvements in sleep, appetite and
functioning can be seen during:
week 2
week 3
week 1
week 4
5. Discuss why tricyclics and MAOIs may still be prescribed despite their
association with side effects.
They are less effective than newer medications.
They have fewer side effects than newer antidepressants.
They may be the best fit for some individuals based on their
specific mental health needs.
They are the only available options for treating depression.
6. Describe the significance of the 4-8 week timeline for antidepressants in
mental health treatment.
The 4-8 week timeline is only relevant for older antidepressants.
The 4-8 week timeline indicates that patients may need to be
patient and continue their treatment for several weeks before
experiencing benefits.
The 4-8 week timeline suggests that antidepressants are ineffective.
The 4-8 week timeline means that patients should stop taking the
medication if they don't feel better immediately.
, 7. Describe the role of short-acting benzodiazepines in the management of
anxiety symptoms.
Short-acting benzodiazepines provide rapid relief from acute
anxiety symptoms.
Short-acting benzodiazepines have no effect on anxiety symptoms.
Short-acting benzodiazepines are used for long-term management
of anxiety disorders.
Short-acting benzodiazepines are primarily used to treat depression.
8. What is the primary therapeutic effect of Esketamine in treating depression?
Reduce psychotic episodes
Relieve depression symptoms
Increase anxiety levels
Enhance cognitive function
9. A patient with schizophrenia who has been treated for five years with
antipsychotic medication developed abnormal movements. The patient has:
Malignant neuroleptic syndrome
Tardive dyskinesia
Akathisia
Muscular dystonia
10. If a child undergoing stimulant treatment reports difficulty sleeping and is
not growing as expected, what steps should a healthcare provider
consider?
Switching to a different class of medication immediately.